Streetbeat News

Earnings

XPEL

XPEL reported Q3 earnings of $0.49 per share, missing the analyst consensus estimate of $0.62 by 20.97%. The company also reported quarterly sales of $102.68 million, missing the analyst consensus estimate of $104.70 million by 1.93%. However, this represents a 2.08% increase in earnings and a 14.39% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:02 pm

RBLX

Roblox (NYSE:RBLX) reported Q3 losses of $(0.45) per share, beating the analyst consensus estimate of $(0.51) by 11.76%. This is a 10% increase over losses from the same period last year. However, the company's quarterly sales of $713.20 million missed the analyst consensus estimate of $829.49 million by 14.02%, marking a 4.34% decrease from last year's sales.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 1:02 pm

VCEL

Vericel (NASDAQ:VCEL) reported Q3 losses of $(0.08) per share, a 42.86% increase over losses of $(0.14) per share from the same period last year. The company's quarterly sales of $45.58 million beat the analyst consensus estimate of $45.15 million by 0.95%, a 18.24% increase over sales of $38.55 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:57 pm

RILY

B. Riley Financial reported Q3 losses of $(2.53) per share, a 265.36% decrease YoY. However, the company's sales increased by 48.12% to $462.31 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:56 pm

AY

Atlantica Yield (AY) has announced that it expects its Cash Available for Distribution (CAFD) to be in the lower end of the guidance range of $230M - $250M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:55 pm

AY

Atlantica Sustainable (NASDAQ:AY) reported Q3 earnings of $0.18 per share, beating the analyst consensus estimate of $0.11 by 63.64%. This is a 238.46% increase from the same period last year. However, the company's quarterly sales of $303.96 million missed the analyst consensus estimate of $326.48 million by 6.90%.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:53 pm

CGEM

Cullinan Oncology (NASDAQ:CGEM) reported its Q3 earnings, beating estimated earnings by 1.09% with an EPS of $-0.91 versus an estimate of $-0.92. However, revenue was down $0 from the same period last year. Last quarter, the company beat on EPS by $0.15, which was followed by a 5.05% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 12:45 pm

TNGX

Tango Therapeutics (NASDAQ:TNGX) reported Q3 earnings, beating estimated earnings by 32.35% with an EPS of $-0.23 versus an estimate of $-0.34. Revenue was up $3.81 million from the same period last year. Last quarter, the company beat EPS by $0.11, which was followed by an 11.34% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 12:45 pm

AKBA

Akebia Therapeutics has reaffirmed its FY23 net product revenue guidance for Auryxia at $170M - $175M. The Q3 net product revenue for Auryxia was $40.1M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:42 pm

SPHR

Sphere Entertainment (NYSE:SPHR) reported Q1 earnings of $1.90 per share, a 240.74% increase YoY. However, sales decreased by 4.16% to $118.01 million compared to $123.13 million in the same period last year.

Portfolio Pulse from bharat@benzinga.com

November 08, 2023 | 12:39 pm